KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Exchange Rate Effect: 2012-2025

Historic Exchange Rate Effect for Zoetis (ZTS) over the last 14 years, with Sep 2025 value amounting to $5.0 million.

  • Zoetis' Exchange Rate Effect rose 200.00% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year increase of 236.36%. This contributed to the annual value of -$32.0 million for FY2024, which is 357.14% down from last year.
  • As of Q3 2025, Zoetis' Exchange Rate Effect stood at $5.0 million, which was down 87.18% from $39.0 million recorded in Q2 2025.
  • Zoetis' 5-year Exchange Rate Effect high stood at $39.0 million for Q2 2025, and its period low was -$18.0 million during Q3 2022.
  • In the last 3 years, Zoetis' Exchange Rate Effect had a median value of -$3.0 million in 2023 and averaged $400,000.
  • As far as peak fluctuations go, Zoetis' Exchange Rate Effect slumped by 700.00% in 2024, and later surged by 587.50% in 2025.
  • Zoetis' Exchange Rate Effect (Quarterly) stood at -$12.0 million in 2021, then climbed by 25.00% to -$9.0 million in 2022, then soared by 66.67% to -$3.0 million in 2023, then crashed by 333.33% to -$13.0 million in 2024, then surged by 200.00% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $39.0 million for Q2 2025, and -$1.0 million during Q1 2025.